ENvue Medical, Inc. (FEED) stock
FEEDOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$0.50+0.13 (+34.73%)
Close on Oct 19, 2026Market cap $3.08MP/E –Yield –
ENvue Medical gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
ENvue Medical's gross profit for the twelve months ending Jun 30, 2026 was -$502.00K, down 166.9% year over year. For fiscal 2025 it was $153.00K, down 89.9% from the year before. Over ten years it grew 4.6% a year on average. The highest annual figure on record is $1.54M in fiscal 2023.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $153.00K | -89.9% |
| FY2024 | Dec 31, 2024 | $1.51M | -1.9% |
| FY2023 | Dec 31, 2023 | $1.54M | +820.4% |
| FY2022 | Dec 31, 2022 | $167.00K | -78.3% |
| FY2021 | Dec 31, 2021 | $770.00K | +259.8% |
| FY2020 | Dec 31, 2020 | $214.00K | -23.8% |
| FY2019 | Dec 31, 2019 | $281.00K | +75.6% |
| FY2018 | Dec 31, 2018 | $160.00K | +6.0% |
| FY2017 | Dec 31, 2017 | $151.00K | +7.1% |
| FY2016 | Dec 31, 2016 | $141.00K | +43.9% |
| FY2015 | Dec 31, 2015 | $98.00K | -10.9% |
| FY2014 | Dec 31, 2014 | $110.00K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$266.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$55.00K | -114.9% |
| Q4 FY2025 | Dec 31, 2025 | -$370.00K | -230.7% |
| Q3 FY2025 | Sep 30, 2025 | $189.00K | +42.1% |
| Q2 FY2025 | Jun 30, 2025 | -$35.00K | -108.2% |
| Q1 FY2025 | Mar 31, 2025 | $369.00K | -44.4% |
| Q4 FY2024 | Dec 31, 2024 | $283.00K | -61.6% |
| Q3 FY2024 | Sep 30, 2024 | $133.00K | -61.9% |
| Q2 FY2024 | Jun 30, 2024 | $428.00K | +98.1% |
| Q1 FY2024 | Mar 31, 2024 | $664.00K | +182.6% |
| Q4 FY2023 | Dec 31, 2023 | $737.00K | – |
| Q3 FY2023 | Sep 30, 2023 | $349.00K | +336.3% |
| Q2 FY2023 | Jun 30, 2023 | $216.00K | -23.1% |
| Q1 FY2023 | Mar 31, 2023 | $235.00K | +121.7% |
| Q4 FY2022 | Dec 31, 2022 | -$300.00K | -216.7% |
| Q3 FY2022 | Sep 30, 2022 | $80.00K | -64.9% |
| Q2 FY2022 | Jun 30, 2022 | $281.00K | +35.1% |
| Q1 FY2022 | Mar 31, 2022 | $106.00K | +37.7% |
| Q4 FY2021 | Dec 31, 2021 | $257.00K | +888.5% |
| Q3 FY2021 | Sep 30, 2021 | $228.00K | +130.3% |
| Q2 FY2021 | Jun 30, 2021 | $208.00K | +447.4% |
| Q1 FY2021 | Mar 31, 2021 | $77.00K | +51.0% |
| Q4 FY2020 | Dec 31, 2020 | $26.00K | – |
| Q3 FY2020 | Sep 30, 2020 | $99.00K | +110.6% |
| Q2 FY2020 | Jun 30, 2020 | $38.00K | -81.6% |
| Q1 FY2020 | Mar 31, 2020 | $51.00K | -3.8% |
| Q4 FY2019 | Dec 31, 2019 | -$26.00K | -236.8% |
| Q3 FY2019 | Sep 30, 2019 | $47.00K | +487.5% |
| Q2 FY2019 | Jun 30, 2019 | $207.00K | +168.8% |
| Q1 FY2019 | Mar 31, 2019 | $53.00K | -3.6% |
| Q4 FY2018 | Dec 31, 2018 | $19.00K | -50.0% |
| Q3 FY2018 | Sep 30, 2018 | $8.00K | -81.4% |
| Q2 FY2018 | Jun 30, 2018 | $77.00K | +126.5% |
| Q1 FY2018 | Mar 31, 2018 | $55.00K | +52.8% |
| Q4 FY2017 | Dec 31, 2017 | $38.00K | -5.0% |
| Q3 FY2017 | Sep 30, 2017 | $43.00K | – |
| Q2 FY2017 | Jun 30, 2017 | $34.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $36.00K | – |
| Q2 FY2016 | Jun 30, 2016 | $40.00K | – |
See a number that looks wrong?